SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-00-007055
Filing Date
2000-08-14
Accepted
2000-08-14 00:00:00
Documents
12
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR QUARTER ENDED JUNE 30, 2000 e10-q.txt 10-Q 56765
2 PLAN OF REORGANIZATION AND MERGER ex2-1.txt EX-2.1 16665
3 CERTIFICATE OF INCORPORATION OF THE COMPANY ex3-1.txt EX-3.1 19557
4 BYLAWS OF THE COMPANY ex3-2.txt EX-3.2 43441
5 FORM OF STOCK CERTIFICATE REPRESENTING COMMON STK ex4-1.txt EX-4.1 2193
6 LEASE AGREEMENT WITH CLEMATIS LLC ex10-1.txt EX-10.1 20391
7 1ST AMENDMENT TO COMMERCIAL LEASE ex10-2.txt EX-10.2 1843
8 2000 EMPLOYEE STOCK COMPENSATION PLAN ex10-3.txt EX-10.3 52574
9 FORM OF NONQUALIFIED STOCK OPTION AGREEMENT ex10-4.txt EX-10.4 8935
10 FORM OF INCENTIVE STOCK OPTION AGREEMENT ex10-5.txt EX-10.5 10005
11 EMPLOYEE AGREEMENT - FENEL ELOI ex10-6.txt EX-10.6 23444
12 FINANCIAL DATA SCHEDULE ex27.txt EX-27 2259
  Complete submission text file 0000950134-00-007055.txt   261295
Mailing Address 100 NE LOOP 410 STE 820 SAN ANTONIO TX 78216
Business Address 100 NE LOOP 410 STE 820 SAN ANTONIO TX 78216-4749 2103496400
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23413 | Film No.: 700212
SIC: 8071 Services-Medical Laboratories